Cargando…

Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan

IMPORTANCE: The use of sodium-glucose transport protein 2 (SGLT2) inhibitors is currently a standard intervention in patients with type 2 diabetes (T2DM) and exerts favorable pleiotropic effects to consistently lower blood urate levels. However, to date, no association between SGLT2 inhibitor use an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Mu-Chi, Hung, Peir-Haur, Hsiao, Po-Jen, Wu, Laing-You, Chang, Chao-Hsiang, Wu, Ming-Ju, Shieh, Jeng-Jer, Chung, Chi-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605485/ https://www.ncbi.nlm.nih.gov/pubmed/34797368 http://dx.doi.org/10.1001/jamanetworkopen.2021.35353

Ejemplares similares

Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2023)

Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis
por: Chung, Mu-Chi, et al.
Publicado: (2022)

Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2020)

Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes
por: Wei, Jie, et al.
Publicado: (2023)

Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan
por: Su, Yu-Chen, et al.
Publicado: (2022)

Association of Obstructive Sleep Apnea With the Risk of Male Infertility in Taiwan
por: Jhuang, Yi-Han, et al.
Publicado: (2021)

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021)

Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy
por: Chang, Yu-Teng, et al.
Publicado: (2021)

Sodium glucose co-transport 2 inhibitors for gout treatment
por: Somagutta, Manoj Kumar Reddy, et al.
Publicado: (2022)

Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study
por: Chen, Tien-Hsing, et al.
Publicado: (2020)

Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma: A 12-Year Nationwide Follow-Up Study
por: Hung, Peir-Haur, et al.
Publicado: (2014)

Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy
por: Hung, Peir-Haur, et al.
Publicado: (2016)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Anti-EMT and anti-fibrosis effects of protocatechuic aldehyde in renal proximal tubular cells and the unilateral ureteral obstruction animal model
por: Chang, Yu-Teng, et al.
Publicado: (2022)

Urinary Klotho Excretion: A Key Regulator of Sodium Homeostasis in Chronic Kidney Disease Stage 2–4
por: Chi, Po-Jui, et al.
Publicado: (2023)

Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone
por: Niu, Sheng-Wen, et al.
Publicado: (2022)

Time to Benefit of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients With Heart Failure
por: Chen, KangYu, et al.
Publicado: (2023)

Primary aldosteronism is associated with risk of urinary bladder stones in a nationwide cohort study
por: Chung, Mu-Chi, et al.
Publicado: (2021)

Correlation Between Bladder Pain Syndrome/Interstitial Cystitis and Pelvic Inflammatory Disease
por: Chung, Shiu-Dong, et al.
Publicado: (2015)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
por: Lee, Hsiang-Chun, et al.
Publicado: (2019)

Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2019)

Investigation of the Impact of Endodontic Therapy on Survival among Dialysis Patients in Taiwan: A Nationwide Population-Based Cohort Study
por: Chiu, Chih-Chien, et al.
Publicado: (2021)

Epidemiology and Risk Factors for Notifiable Scrub Typhus in Taiwan during the Period 2010–2019
por: Lin, Fu-Huang, et al.
Publicado: (2021)

Long-term exposure to air pollutants and increased risk of chronic kidney disease in a community-based population using a fuzzy logic inference model
por: Lin, Hsueh-Chun, et al.
Publicado: (2022)

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
por: Arow, M., et al.
Publicado: (2020)

Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study
por: Chuang, Jen-Pin, et al.
Publicado: (2019)

The Most Common Location of Schools with Viral Upper Respiratory Tract Infection Clusters in Taiwan, 2011–2019
por: Lin, Fu-Huang, et al.
Publicado: (2022)

High glucose induces human endothelial dysfunction through an Axl-dependent mechanism
por: Lee, Chien-Hsing, et al.
Publicado: (2014)

Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors
por: Sheu, Wayne H‐H
Publicado: (2020)

Infections and risk of end-stage renal disease in patients with nephrotic syndrome: a nationwide population-based case-control study
por: Lin, Chien-Hung, et al.
Publicado: (2020)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
por: Li, Hang-Long, et al.
Publicado: (2021)

The Epidemiology of Entamoeba histolytica Infection and Its Associated Risk Factors among Domestic and Imported Patients in Taiwan during the 2011–2020 Period
por: Lin, Fu-Huang, et al.
Publicado: (2022)

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor
por: Lee, Hsin-Fu, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan
por: Chang, Chia-Yu, et al.
Publicado: (2017)

Association of Sodium-Glucose Cotransporter–2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
por: Zhuo, Min, et al.
Publicado: (2021)

Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
por: Xie, Yan, et al.
Publicado: (2021)

Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Increased Risk of Post-Transplant Malignancy and Mortality in Transplant Tourists: A Nationwide Population-Based Cohort Study in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2014)

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
por: Chen, Chung-Jen, et al.
Publicado: (2018)

Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan
por: Lu, Chieh-Hua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e6q9u37o36muka1v4k50ekutvp